SynthesisInvestigational new drugs2022

Toxicity profile of anaplastic lymphoma kinase tyrosine kinase inhibitors for patients with non-small cell lung cancer: A systematic review and meta-analysis.

Yunxia Tao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.